Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Santen patents novel strategy for allergic conjunctivitis

Sep. 20, 2006

No Comments

Phase IIa study of microplasmin in vitrectomy completes treatment

Sep. 19, 2006

No Comments

Preclinical testing for Advanced Refractive Technologies' novel glaucoma treatment

Sep. 15, 2006

No Comments

Bevasiranib shows biological effect in wet AMD

Sep. 14, 2006

No Comments

Oxigene updates CA4P ophthalmology strategy and trial status

Sep. 14, 2006

No Comments

Israeli approval for phase II study of CF-101 in keratoconjunctivitis sicca

Sep. 8, 2006

No Comments

New strategies for treatment of glaucoma reported in recent patents

Sep. 1, 2006

No Comments

First European approval for Lucentis in Switzerland

Aug. 29, 2006

No Comments

AzaSite NDA accepted for review

Aug. 29, 2006

No Comments

ATG-003 begins phase I testing for AMD

Aug. 23, 2006

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Santen patents novel strategy for allergic conjunctivitis

Phase IIa study of microplasmin in vitrectomy completes treatment

Preclinical testing for Advanced Refractive Technologies' novel glaucoma treatment

Bevasiranib shows biological effect in wet AMD

Oxigene updates CA4P ophthalmology strategy and trial status

Israeli approval for phase II study of CF-101 in keratoconjunctivitis sicca

New strategies for treatment of glaucoma reported in recent patents

First European approval for Lucentis in Switzerland

AzaSite NDA accepted for review

ATG-003 begins phase I testing for AMD

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Ocular RSS

Ocular
RSS